Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109615

Attenuation of Angiotensin II- and III-induced Aldosterone Release by Prostaglandin Synthesis Inhibitors

William B. Campbell, Celso E. Gomez-Sanchez, Beverley V. Adams, James M. Schmitz, and Harold D. Itskovitz

Department of Pharmacology, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Medical College of Wisconsin, Milwaukee County General Hospital, Milwaukee, Wisconsin 53233

Find articles by Campbell, W. in: PubMed | Google Scholar

Department of Pharmacology, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Medical College of Wisconsin, Milwaukee County General Hospital, Milwaukee, Wisconsin 53233

Find articles by Gomez-Sanchez, C. in: PubMed | Google Scholar

Department of Pharmacology, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Medical College of Wisconsin, Milwaukee County General Hospital, Milwaukee, Wisconsin 53233

Find articles by Adams, B. in: PubMed | Google Scholar

Department of Pharmacology, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Medical College of Wisconsin, Milwaukee County General Hospital, Milwaukee, Wisconsin 53233

Find articles by Schmitz, J. in: PubMed | Google Scholar

Department of Pharmacology, University of Texas Health Science Center, Dallas, Texas 75235

Department of Internal Medicine, University of Texas Health Science Center, Dallas, Texas 75235

Medical College of Wisconsin, Milwaukee County General Hospital, Milwaukee, Wisconsin 53233

Find articles by Itskovitz, H. in: PubMed | Google Scholar

Published December 1, 1979 - More info

Published in Volume 64, Issue 6 on December 1, 1979
J Clin Invest. 1979;64(6):1552–1557. https://doi.org/10.1172/JCI109615.
© 1979 The American Society for Clinical Investigation
Published December 1, 1979 - Version history
View PDF
Abstract

The effect of two prostaglandin synthesis inhibitors, indomethacin and meclofenamate, on angiotensin II (AII)- and III (AIII)-induced aldosterone release was studied in normal and sodium-depleted conscious rats and in adrenal capsular cell suspensions obtained from normal rats. In normal rats, in vivo AII and AIII were equipotent in causing dose-related increases in serum aldosterone concentrations. Indomethacin decreased the basal serum aldosterone levels by 50% and serum renin levels by 43%. In addition, the steroidogenic effects of AII and AIII were reduced by 45 and 63% with 3 mg/kg of indomethacin and 63 and 73% with 10 mg/kg, respectively. In contrast, meclofenamate failed to alter basal serum levels of aldosterone or AII-stimulated aldosterone release but inhibited serum renin levels by 27% and the aldosterone-stimulating effect of AIII by 99%. Indomethacin (3 mg/kg) and meclofenamate (2 mg/kg) inhibited urinary prostaglandin (PG)E2 and PGF2α excretion by 63 and 52% and 37 and 31%, respectively. Both inhibitors significantly decreased the adrenal capsular PGE2 and PGF2α content and the conversion of [14C]arachidonate to [14C]PGE2 and [14C]PGF2α. In sodium-depleted rats, indomethacin produced similar effects reducing the control serum aldosterone levels by 29%, AII-stimulated aldosterone by 47%, and completely suppressing the aldosterone response to AIII without altering serum renin activity. In adrenal cell suspensions, similar results were observed with indomethacin inhibiting basal and AII- and AIII-stimulated aldosterone release by 29, 81, and 93%, respectively. Meclofenamate failed to alter basal and AII-stimulated aldosterone release but inhibited that stimulated by AIII by 86%. The present findings suggest that prostaglandins modulate the effects of the renin-angiotensin system by stimulating the release of renin from the kidney and augmenting the steroidogenic effects of AII and AIII in the adrenal cortex.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1552
page 1552
icon of scanned page 1553
page 1553
icon of scanned page 1554
page 1554
icon of scanned page 1555
page 1555
icon of scanned page 1556
page 1556
icon of scanned page 1557
page 1557
Version history
  • Version 1 (December 1, 1979): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts